Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that reactivation of herpesviruses, especially HHV-6, is linked to severe symptoms and complications in drug-induced hypersensitivity syndrome.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

CAP7.1 is generally safe at 200 mg/m²/day, but can cause fatigue, nausea, hair loss, fever, and blood-related issues.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Cyproterone acetate can effectively treat idiopathic hirsutism, but ethinyl oestradiol and lynoestrenol may not always reduce hair growth.

Tedisamil and glibenclamide affect cromakalim and minoxidil sulphate differently in rat aorta.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Doxazosin alone or combined with finasteride improves prostate symptoms better than finasteride alone, without extra benefits.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Zinc sulphate solution was not effective in reducing the number, duration, or severity of recurrent herpes simplex infections.

A new treatment effectively kills antibiotic-resistant bacteria and helps wounds heal faster by boosting the immune response.

The microreactor effectively fights antibiotic-resistant infections and promotes tissue healing.

Six existing drugs may help block virus entry in COVID-19.

Using Cyproterone Acetate with Eflornithine together is safe and works better for treating facial hair in women.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Fludalanine failed as an effective oral antibiotic despite efforts.

The document concludes that specific methods for making diazine-based drugs can lead to high yields and are important for creating effective treatments for various diseases.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

Ruxolitinib treatment may cause eyelash growth.

ZO-1 helps hair follicle stem cells renew better by changing their structure.